natgillin/translations-raw huggingface dataset:
The rates of severe hypoglycaemia (affected participants per 100 participant years of exposure) were 1.05 for insulin glargine and 0.30 for standard care group and the rates of confirmed non-severe hypoglycaemia were 7.71 for insulin glargine and 2.44 for standard care group. 
1,05 u skupini koja je primala inzulin glargin i 0,30 u skupini koja je primala standardno liječenje, dok je stopa potvrđene hipoglikemije koja se nije smatrala teškom iznosila 7,71 u skupini koja je primala inzulin glargin te 2,44 u skupini koja je primala standardno liječenje.
LABEL (5 ml vial) 
NALJEPNICA (bočica od 5 ml)
EU/1/00/134/001 1 vial of 5 ml EU/1/00/134/002 2 vials of 5 ml EU/1/00/134/003 5 vials of 5 ml EU/1/00/134/004 10 vials of 5 ml 
EU/1/00/134/002 2 bočice od 5 ml EU/1/00/134/003 5 bočica od 5 ml EU/1/00/134/004 10 bočica od 5 ml
Effects of insulin glargine (once daily) on diabetic retinopathy were evaluated in an open-label 5 year NPH-controlled study (NPH given bid) in 1024 type 2 diabetic patients in which progression of retinopathy by 3 or more steps on the Early Treatment Diabetic Retinopathy Study (ETDRS) scale was investigated by fundus photography. 
godišnjem otvorenom kliničkom ispitivanju kontroliranom NPH inzulinom (NPH primijenjen dvaput na dan) na 1024 bolesnika sa šećernom bolešću tipa 2, u kojih je progresija retinopatije za više od 3
Once in use, the 5 ml vial may be stored for a maximum of 4 weeks in the outer carton not above 25°C and away from direct heat or direct light. 
Kad je u uporabi, bočica od 5 ml može se čuvati najdulje 4 tjedna u vanjskom pakiranju na temperaturi do 25°C, zaštićena od izvora topline i izravne svjetlosti.
- The other ingredients are: zinc chloride, metacresol, glycerol, sodium hydroxide (see section 2 “Important information about some of the ingredients of Lantus”) and hydrochloric acid (for pH adjustment), polysorbate 20 (10 ml vial only) and water for injections. 
- Drugi sastojci su: cinkov klorid, metakrezol, glicerol, natrijev hidroksid (vidjeti dio 2 "Važne informacije o nekim sastojcima lijeka Lantus") i kloridna kiselina (za prilagodbu pH), polisorbat 20 (samo bočica od 10 ml) i voda za injekcije.
Examples include: - you inject too much insulin, - you miss meals or delay them, - you do not eat enough, or eat food containing less carbohydrate than normal (sugar and substances similar to sugar are called carbohydrates; however, artificial sweeteners are NOT 
- ako preskočite ili odgodite obrok, - ako ne jedete dovoljno ili jedete hranu koja sadrži manje ugljikohidrata nego što je uobičajeno
Use only clear and colourless solutions. 
Primijeniti samo bistru i bezbojnu otopinu.
Unopened: 
Neotvoreni ulošci:
Substances that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia include oral antidiabetic medicinal products, angiotensin converting enzyme (ACE) inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, pentoxifylline, propoxyphene, salicylates and sulfonamide antibiotics. 
Tvari koje mogu pojačati učinak na snižavanje razine glukoze u krvi i povećati sklonost hipoglikemiji obuhvaćaju oralne antidijabetike, inhibitore angiotenzin konvertirajućeg enzima (ACE), dizopiramid,
If you have injected too much Lantus, your blood sugar level may become too low (hypoglycaemia). 
Ako ste injicirali previše lijeka Lantus, razina šećera u krvi može postati preniska (hipoglikemija).
If administration by syringe is necessary, a vial should be used (see section 4.2). 
. Ako je potrebna primjena pomoću štrcaljke, potrebno je koristiti bočicu (vidjeti dio 4.2).
Discard your used SoloStar as required by your local authorities. 
Upotrijebljenu SoloStar brizgalicu potrebno je zbrinuti sukladno lokalnim propisima.
- The other ingredients are: zinc chloride, metacresol, glycerol, sodium hydroxide (see section 2 “Important information about some of the ingredients of Lantus”) and hydrochloric acid (for pH adjustment) and water for injections. 
- Drugi sastojci su: cinkov klorid, metakrezol, glicerol, natrijev hidroksid (vidjeti dio 2 "Važne informacije o nekim sastojcima lijeka Lantus") i kloridna kiselina (za prilagodbu pH) i voda za injekcije.
Such reactions to insulin (including insulin glargine) or the excipients may, for example, be associated with generalised skin reactions, angio-oedema, bronchospasm, hypotension and shock, and may be life-threatening. 
Takve reakcije na inzulin (uključujući inzulin glargin) ili na pomoćne tvari mogu, primjerice, biti povezane s generaliziranim kožnim reakcijama,
Each ml of the solution contains 100 units of insulin glargine (equivalent to 3.64 mg). 
Jedan ml otopine sadrži 100 jedinica inzulina glargina (što odgovara 3,64 mg).
Each pen contains 3 ml of solution for injection (equivalent to 300 units). 
Jedan uložak sadrži 3 ml otopine za injekciju (što odgovara 300 jedinica).
If you have any questions about SoloStar or about diabetes, ask your doctor, pharmacist or nurse or call the local representative number on the front of this leaflet. 
ljekarniku ili medicinskoj sestri ili nazovite broj lokalnog predstavnika naveden na prednjoj strani ove upute.
The pen containing the cartridge must not be stored in the refrigerator. 
Brizgalica koja sadrži uložak ne smije se odlagati u hladnjak.
Each cartridge or pen contains 3 ml of solution for injection, equivalent to 300 units. 
Jedan uložak ili jedna napunjena brizgalica sadrže 3 ml otopine za injekciju, što odgovara 300 jedinica.
• Skin and allergic reactions at the injection site The signs may include reddening, unusually intense pain when injecting, itching, hives, swelling or inflammation. 
Znakovi mogu uključivati crvenilo, neuobičajeno jaku bol prilikom injiciranja, svrbež, osip, oticanje ili upalu.
Method of administration Lantus is administered subcutaneously. 
Lantus se primjenjuje supkutano.
Unopened vials, unopened cartridges, not in-use SoloStar pens Store in a refrigerator (2°C-8°C). 
Neotvorene bočice Čuvati u hladnjaku (2°C-8°C).
Do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after “EXP”. 
Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i naljepnici na ulošku iza "EXP".
Each cartridge contains 3 ml of solution for injection (equivalent to 300 units). 
Jedna brizgalica sadrži 3 ml otopine za injekciju (što odgovara 300 jedinica).
Musculoskeletal and connective tissue disorders 
Poremećaji mišićno koštanog sustava i vezivnog tkiva mialgija
Once in use, the 10 ml vial may be stored for a maximum of 4 weeks in the outer carton not above 30°C and away from direct heat or direct light. 
Kad je u uporabi, bočica od 10 ml može se čuvati najdulje 4 tjedna u vanjskom pakiranju na temperaturi do 30°C, zaštićena od izvora topline i izravne svjetlosti.
Clear colourless solution. 
Bistra, bezbojna otopina.
Type 1 colourless glass vial with a flanged cap (aluminium), a stopper (chlorobutyl rubber (type 1)) and a tear-off cap (polypropylene) containing 5 ml of solution. 
Bočica od bezbojnog stakla tipa 1 sa zatvaračem s rubnikom (aluminij), čepom (klorobutilna guma (tip 1)) i zatvaračem koji se otkida (polipropilen) sadrži 5 ml otopine.
Type 1 colourless glass vial with a flanged cap (aluminium), a stopper (type 1, laminate of polyisoprene and bromobutyl rubber) and a tear-off cap (polypropylene) containing 10 ml of solution. 
Bočica od bezbojnog stakla tipa 1 sa zatvaračem s rubnikom (aluminij), čepom (tip 1, poliizoprenski laminat i bromobutilna guma) i zatvaračem koji se otkida (polipropilen) sadrži 10 ml otopine.
Handling of the SoloStar pre-filled pen 
Rukovanje napunjenom brizgalicom SoloStar
Do not use this medicine after the expiry date which is stated on the carton and on the label of the pen after “EXP”. 
Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i naljepnici na brizgalici iza "EXP".
5 vials of 5 ml. 
5 uložaka od 3 ml.
Lantus 100 units/ml solution for injection in a vial is a clear, colourless and waterlike solution. 
Lantus 100 jedinica/ml otopina za injekciju u bočici je bistra, bezbojna i vodenasta otopina.
After its first use, the pen may be stored for a maximum of 4 weeks not above 30°C. 
Nakon prve uporabe, brizgalica se može čuvati najdulje 4 tjedna na temperaturi do 30°C.
Look at the vial before you use it. Only use it if the solution is clear, colourless and waterlike, and has no visible particles in it. Do not shake or mix it before use. 
Smijete je upotrijebiti samo ako je otopina bistra, bezbojna i vodenasta i u njoj nema vidljivih čestica.
Lantus SoloStar solution for injection in a pre-filled pen. 
Lantus SoloStar otopina za injekciju u napunjenoj brizgalici.
Packs of 1, 3, 4, 5, 6, 8, 9 and 10 SoloStar pre-filled pens. 
Pakiranja od 1, 3, 4, 5, 6, 8, 9 i 10 SoloStar napunjenih brizgalica.
These include: - change in the injection area, - improved insulin sensitivity (e.g., by removal of stress factors), - unaccustomed, increased or prolonged physical activity, - intercurrent illness (e.g. vomiting, diarrhoea), - inadequate food intake, - missed meals, - alcohol consumption, - certain uncompensated endocrine disorders, (e.g. in hypothyroidism and in anterior pituitary or adrenocortical insufficiency), - concomitant treatment with certain other medicinal products (see section 4.5). 
Oni obuhvaćaju: - promjenu područja injiciranja, - poboljšanu osjetljivost na inzulin (npr. uklanjanjem čimbenika stresa), - povećanu ili dugotrajnu tjelesnu aktivnost na koju bolesnik nije navikao, - interkurentnu bolest (npr. povraćanje, proljev),
Inject the dose 
Otopina za injekciju
In use pens 
Brizgalice u uporabi
The medicinal product may be stored for a maximum of 4 weeks not above 25°C and away from direct heat or direct light. 
Lijek se može čuvati najdulje 4 tjedna na temperaturi do 25°C, zaštićen od izvora topline i izravne svjetlosti.
Very rare reported side-effects (may affect up to1 in10,000 people) In very rare cases, dysgeusia (taste disorders) and myalgia (muscular pain) can occur. 
U vrlo rijetkim slučajevima mogu nastupiti promjena osjeta okusa (disgeuzija) i bol u mišićima
The medicinal product may be stored for a maximum of 4 weeks not above 30°C and away from direct heat or direct light. 
Lijek se može čuvati najdulje 4 tjedna na temperaturi do 30°C, zaštićen od izvora topline i izravne svjetlosti.
Marketing Authorisation Holder Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Germany. 
Nositelj odobrenja za stavljanje lijeka u promet Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt na Majni, Njemačka.
No new safety signals were seen during this extended treatment with insulin glargine. 
Tijekom tog produljenog liječenja inzulinom glarginom nisu otkriveni novi signali u vezi sa sigurnošću primjene lijeka.
Lantus SoloStar 100 units/ml in pre-filled pen is only suitable for subcutaneous injections. 
Lantus SoloStar 100 jedinica/ml u napunjenoj brizgalici je prikladan samo za potkožne injekcije
Schematic diagram of the pen 
Shematski prikaz brizgalice
Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Germany. 
Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt na Majni, Njemačka.
Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen is a clear and colourless solution. 
Lantus SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici je bistra i bezbojna otopina.
Packs of 1, 3, 4, 5, 6, 8, 9 and 10 cartridges. 
Pakiranja od 1, 3, 4, 5, 6, 8, 9 i 10 uložaka.
Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main, Germany. 
Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt na Majni, Njemačka.
It must only be used if the solution is clear, colourless, with no solid particles visible, and if it is of water-like consistency. 
Bočica se smije koristiti samo ako je otopina bistra, bezbojna, vodenasta i ako nema vidljivih krutih čestica.
Excipients: zinc chloride, metacresol, glycerol, hydrochloric acid and sodium hydroxide (for pH adjustment) and water for injections 
Pomoćne tvari: cinkov klorid, metakrezol, glicerol, kloridna kiselina i natrijev hidroksid (za prilagodbu pH) i voda za injekcije
Lantus is a long-acting insulin. 
Lantus je dugodjelujući inzulin.
Excipients: zinc chloride, metacresol, glycerol, hydrochloric acid and sodium hydroxide (for pH adjustment), polysorbate 20, , water for injections. 
POPIS POMOĆNIH TVARI Pomoćne tvari: cinkov klorid, metakrezol, glicerol, kloridna kiselina i natrijev hidroksid (za prilagodbu pH), polisorbat 20, voda za injekcije.
9 cartridges of 3 ml. 
9 uložaka od 3 ml.
Once in use, vials may be stored for a maximum of 4 weeks not above 25°C. 
Kad su u uporabi, bočice se mogu čuvati najdulje 4 tjedna na temperaturi do 25°C.
Lantus SoloStar 100 units/ml solution for injection insulin glargine 
Lantus SoloStar 100 jedinica/ml otopina za injekciju inzulin glargin
Lantus 100 units/ml in cartridges is only suitable for subcutaneous injections from a reusable pen. 
Lantus 100 jedinica/ml u ulošcima je prikladan samo za potkožne injekcije iz brizgalice za višekratnu uporabu
As in the paediatric study described above, fasting plasma glucose reduction from baseline was greater in the insulin glargine group than in the NPH group. 
smanjenje razine glukoze u plazmi natašte u odnosu na početnu vrijednost bilo je veće u skupini koja je primala inzulin glargin nego u skupini koja je primala NPH inzulin.
Keep the vial in the outer carton in order to protect from light. 
Uložak čuvati u vanjskom pakiranju radi zaštite od svjetlosti.
OUTER CARTON (10 ml vial) 
KUTIJA (bočica od 10 ml)
The Lantus cartridges should only be used with the following pens: - JuniorSTAR which delivers Lantus in 0.5 unit dose increments - ClikSTAR, Tactipen, Autopen 24, AllStar and AllStar PRO which all deliver Lantus in 1 unit dose increments. 
- JuniorSTAR, kojim se može dozirati lijek Lantus u koracima od 0,5 jedinica - ClikSTAR, Tactipen, Autopen 24, AllStar i AllStar PRO, kojima se može dozirati lijek Lantus u koracima od 1 jedinice.
10 cartridges of 3 ml. 
10 uložaka od 3 ml.
- diuretics (used to treat high blood pressure or excessive fluid retention), - glucagon (pancreas hormone used to treat severe hypoglycaemia), - isoniazid (used to treat tuberculosis), - oestrogens and progestogens (such as in the contraceptive pill used for birth control), - phenothiazine derivatives (used to treat psychiatric disorders), - somatropin (growth hormone), - sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma), - thyroid hormones (used to treat thyroid gland disorders), - atypical antipsychotic medicines (such as clozapine, olanzapine), - protease inhibitors (used to treat HIV). 
- somatropin (hormon rasta), - simpatomimetičke lijekove (poput epinefrina [adrenalina], salbutamola, terbutalina koji se koriste za liječenje astme), - hormone štitnjače (koriste se za liječenje poremećaja štitnjače), - netipične antipsihotičke lijekove (kao što su klozapin, olanzapin), - inhibitore proteaze (koriste se za liječenje HIV infekcije).
Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen Lantus SoloStar 100 units/ml in pre-filled pen is only suitable for subcutaneous injections. 
Lantus SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici Lantus SoloStar 100 jedinica/ml u napunjenoj brizgalici je prikladan samo za potkožne injekcije.
Medicinal product subject to medical prescription 
NAČIN PRIMJENE LIJEKA Za potkožnu primjenu
4 cartridges of 3 ml. 
4 uloška od 3 ml.
Pack sizes of 1, 3, 4, 5, 6, 8, 9 and 10 pre-filled pens. 
Pakiranja od 1, 3, 4, 5, 6, 8, 9 i 10 napunjenih brizgalica.
6 cartridges of 3 ml. 
6 uložaka od 3 ml.
Lantus 100 units/ml solution for injection in a cartridge is a clear and colourless solution. 
Lantus 100 jedinica/ml otopina za injekciju u ulošku je bistra i bezbojna otopina.
See the reverse (insulin) side of this leaflet for instructions on how to store SoloStar. 
Za upute za čuvanje SoloStar brizgalice pogledajte stražnju (inzulinsku) stranu ove upute o lijeku.
Lantus 100 units/ml solution for injection in a cartridge, Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen 
Lantus 100 jedinica/ml otopina za injekciju u ulošku, Lantus SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici
Do not use Lantus if you notice particles in it. Only use Lantus if the solution is clear, colourless and waterlike. 
Lantus smijete upotrijebiti samo ako je otopina bistra, bezbojna i vodenasta.
Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens, phenothiazine derivatives, somatropin, sympathomimetic medicinal products (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, atypical antipsychotic medicinal products (e.g. clozapine and olanzapine) and protease inhibitors. 
somatropin, simpatomimetičke lijekove (npr. epinefrin [adrenalin], salbutamol, terbutalin), hormone štitnjače, atipične antipsihotike (npr. klozapin i olanzapin) te inhibitore proteaze.
Lantus 100 units/ml solution for injection in a cartridge Lantus 100 units/ml in cartridges is only suitable for subcutaneous injections from a reusable pen. 
Lantus 100 jedinica/ml otopina za injekciju u ulošku Lantus 100 jedinica/ml u ulošcima je prikladan samo za potkožne injekcije iz brizgalice za višekratnu uporabu.
Pens to be used with Lantus 100 units/ml in cartridges Lantus 100 units/ml in cartridges is only suitable for subcutaneous injections from a reusable pen. 
Brizgalice koje se moraju koristiti s lijekom Lantus 100 jedinica/ml u ulošcima Lantus 100 jedinica/ml u ulošcima je prikladan samo za potkožne injekcije iz brizgalice za višekratnu uporabu..
Posology 
PODLOŽAK
E. Press the injection button all the way in. 
Pritisnite dugme za injiciranje do kraja.
- in whom an autonomic neuropathy is present, - with a long history of diabetes, - suffering from a psychiatric illness, - receiving concurrent treatment with certain other medicinal products (see section 4.5). 
- neke nekompenzirane endokrine poremećaje (npr. kod hipotireoze i insuficijencije adenohipofize ili kore nadbubrežne žlijezde), - istodobno liječenje određenim drugim lijekovima (vidjeti dio 4.5).
3 cartridges of 3 ml. 
3 uloška od 3 ml.
OUTER CARTON (Pre-filled pen. 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA (Napunjena brizgalica.
You may need to talk about 
Ako sumnjate da je
Lantus 100 units/ml solution for injection in a vial It is important to ensure that syringes do not contain traces of any other material. 
Važno je osigurati da štrcaljke ne sadrže tragove bilo kakvih drugih tvari.
Insulin mix-ups 
Inzulin glargin NPH inzulin
See the box at the end of this leaflet for further information. 
pogledajte uokvireni tekst na kraju ove upute o lijeku.
Lantus 100 units/ml solution for injection in a vial Lantus 100 units/ml solution for injection in a cartridge Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen 
Lantus 100 jedinica/ml otopina za injekciju u ulošku Lantus SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici
Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen Insulin glargine 
Lantus SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici inzulin glargin
Lantus 100 units/ml solution for injection insulin glargine 
Lantus 100 jedinica/ml otopina za injekciju inzulin glargin
Once in use, vials may be stored for a maximum of 4 weeks not above 30°C. 
Ulošci u uporabi mogu se čuvati najdulje 4 tjedna na temperaturi do 30°C.
Retinopathy 
Simptomi
Consult your insulin pen instruction booklet for further details. 
Za detaljne informacije pogledajte knjižicu s uputama za uporabu brizgalice.
Pre-filled pens in use or carried as a spare may be stored for a maximum of 4 weeks not above 30°C and away from direct heat or direct light.The pen in use must not be stored in the refrigerator Do not use it after this time period. 
Napunjene brizgalice u uporabi ili rezervne brizgalice mogu se čuvati najdulje 4 tjedna na temperaturi do 30°C, zaštićene od izvora topline i izravne svjetlosti.
Step 6. 
4. korak Odabir doze
Read the package leaflet before use. 
Pregledajte uložak prije nego što ga upotrijebite.
This helps prevent: 
One obuhvaćaju bolesnike:
HYPERGLYCAEMIA (high blood sugar levels) 
- ako imate hiperglikemiju (visoku razinu šećera u krvi),
What Lantus contains 
Sadržaj pakiranja i druge informacije Što Lantus sadrži
Do not use SoloStar if you notice particles in it. Only use SoloStar if the solution is clear, colourless and waterlike. 
Smijete ga upotrijebiti samo ako je otopina bistra, bezbojna i vodenasta.
Subcutaneous use Open here 
Otvoriti ovdje
Select the dose 
UPUTA O LIJEKU
Lantus 100 units/ml solution for injection in a cartridge Insulin glargine 
Lantus 100 jedinica/ml otopina za injekciju u ulošku inzulin glargin
Injection site reactions 
Opći poremećaji i reakcije na mjestu primjene reakcije na mjestu injiciranja edem
It usually appears between 40 and 50 years of age. 
Obično se javlja u dobi između 40 i 50 godina.
The absolute risk reduction was 4.2%. 
Smanjenje apsolutnog rizika iznosilo je 4,2%.
The median follow-up duration was 22.9 months. 
Medijan perioda praćenja bio je 22,9 mjeseci.
Ask your pharmacist how to throw away medicines you no longer use. 
Pitajte svog ljekarnika kako bacati lijekove koje više ne koristite.
Luminous phenomena (phosphenes) 
Svjetlosni fenomeni (fosfeni)
Do not take a double dose to make up for the forgotten dose. 
Nemojte uzeti dvostruku dozu kako biste nadoknadili zaboravljenu dozu.
The higher than approved dose used in the study did not fully explain these findings. 
Veća doza lijeka od odobrene korištena u ispitivanju nije u potpunosti objasnila ove rezultate.
In this way Corlentor helps to control and reduce the number of angina attacks. 
Na taj način, Corlentor pomaže u kontroliranju i smanjenju broja napadaja angine.
Uncontrolled blood pressure 
Nekontrolirani krvni tlak
The potential risk for humans is unknown. 
Nije poznato koliki je potencijalni rizik primjene u ljudi.
About 4% of an oral dose is excreted unchanged in urine. 
Oko 4% oralne doze izlučuje se nepromijenjeno u urinu.
Corlentor should be taken during meals. 
Corlentor treba uzimati tijekom obroka.
Headache, generally during the first month of treatment 
Glavobolja, obično tijekom prvog mjeseca liječenja
If you forget to take a dose of Corlentor, take the next dose at the usual time. 
Ako zaboravite uzeti jednu dozu Corlentora, uzmite sljedeću dozu u uobičajeno vrijeme.
Do not throw away any medicine via wastewater or household waste. 
Nikada nemojte nikakve lijekove bacati u otpadne vode ili kućni otpad.
ibutilide, amiodarone). 
ibutilid, amiodaron).
Like all medicines, this medicine can cause side effects, although not everybody gets them. 
Kao i svi lijekovi, ovaj lijek može uzrokovati nuspojave, iako se neće javiti kod svakoga.
Hazard ratio [95% CI] 
Omjer ugroženosti [95% CI]
If this happens, contact your doctor immediately. 
Ako se to dogodi, odmah se obratite liječniku.
Other medicines and Corlentor 
Drugi lijekovi i Corlentor
Elevated creatinine in blood 
Povišena vrijednost kreatinina u krvi
What Corlentor is and what it is used for 
Što je Corlentor i za što se koristi
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. 
Obavijestite svog liječnika ili ljekarnika ako uzimate, ako ste nedavno uzimali ili biste mogli uzeti bilo koje druge lijekove.
Children Corlentor is not intended for use in children and adolescents younger than 18 years. 
Corlentor nije namijenjen djeci ni mladeži mlađoj od 18 godina.
The MAH shall complete, within the stated timeframe, the below measures: 
Nositelj odobrenja će dovršiti, unutar navedenog vremenskog roka, niže navedenu mjeru:
All phosphenes resolved during or after treatment, of which a majority (77.5%) resolved during treatment. 
Svi su se fosfeni povukli tijekom ili nakon liječenja, od čega se većina (77,5%) povukla tijekom liječenja.
About stable angina pectoris (usually referred to as “angina”): 
O stabilnoj angini pektoris (koja se obično naziva “anginom”):
Very rare: Irregular heart beats. 
Vrlo rijetko: Nepravilni otkucaji srca.